A prodigious number of microbes inhabit the human body, especially in the lumen of the gastrointestinal (GI) tract, yet our knowledge of how they regulate metabolic pathways within our cells is rather limited. To investigate the role of microbiota in host energy metabolism, we analyzed ATP levels and AMPK phosphorylation in tissues isolated from germfree and conventionally-raised C57BL/6 mice. These experiments demonstrated that microbiota are required for energy homeostasis in the proximal colon to a greater extent than other segments of the GI tract that also harbor high densities of bacteria. This tissue-specific effect is consistent with colonocytes utilizing bacterially-produced butyrate as their primary energy source, whereas most other cell types utilize glucose. However, it was surprising that glucose did not compensate for butyrate deficiency. We measured a 3.5-fold increase in glucose uptake in germfree colonocytes. However, 13C-glucose metabolic-flux experiments and biochemical assays demonstrated that they shifted their glucose metabolism away from mitochondrial oxidation/CO2 production and toward increased glycolysis/lactate production, which does not yield enough ATPs to compensate. The mechanism responsible for this metabolic shift is diminished pyruvate dehydrogenase (PDH) levels and activity. Consistent with perturbed PDH function, the addition of butyrate, but not glucose, to germfree colonocytes ex vivo stimulated oxidative metabolism. As a result of this energetic defect, germfree colonocytes exhibited a partial block in the G1-to-S-phase transition that was rescued by a butyrate-fortified diet. These data reveal a mechanism by which microbiota regulate glucose utilization to influence energy homeostasis and cell-cycle progression of mammalian host cells.
Citation: Donohoe DR, Wali A, Brylawski BP, Bultman SJ (2012) Microbial Regulation of Glucose Metabolism and Cell-Cycle Progression in Mammalian Colonocytes. PLoS ONE 7(9): e46589. https://doi.org/10.1371/journal.pone.0046589
Editor: Stefan Bereswill, Charité-University Medicine Berlin, Germany
Received: August 3, 2012; Accepted: September 5, 2012; Published: September 28, 2012
Copyright: © Donohoe et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National Institutes of Health (CA125237 to S.J.B.), the American Institute of Cancer Research, and The Prevent Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Metagenomics projects involving high-throughput/next-generation sequencing are being used to characterize microbial communities within the human body –, yet our knowledge of how microbes influence biochemical and physiological processes in the host is limited. The gastrointestinal (GI) tract harbors the largest density of microbiota, where gut microbes outnumber all of the somatic cells and germ cells in the human body by 10-fold , . Furthermore, if we consider the their collective genomes, referred to as the microbiome, the microbiota have approximately 100 times more genes than our own human genome . Current sequence data shows the gut microbiome is enriched for genes involved in energy production and extraction , , . For example, carbohydrate metabolism is particularly overrepresented with 115 families of glycoside hydrolases and 21 families of polysaccharide lyases , . Humans lack many of these genes presumably because mammals (and their genomes) co-evolved with gut microbiota (and the gut microbiome) , –. As a result, there is a symbiotic relationship where humans and other mammalian hosts ingest carbohydrate-rich diets and provide them to microbiota in a protected environment; in return, the microbiota break down the glycans into disaccharides and monosaccharides for their own use as well as the host , . Because glycans are poorly digested by the host, microbiota are thought to improve the ability of the host to absorb nutrients and extract calories from their diet , .
To study the function of microbiota in host metabolism, germfree (GF) mice, which completely lack microbes, can be compared to genetically identical mice that were raised conventionally (CONV-R) with “normal”, albeit undefined, microbiota. Previous studies have shown that GF mice consume more food to maintain the same body weight as CONV-R controls , . Despite this increased food intake, GF mice are leaner than CONV-R controls and are resistant to obesity induced by a high-fat diet . They also have decreased levels of glycogen, glucose, and insulin . These findings support the idea that microbiota increase metabolic efficiency in the host.
In a previous study, we reported that colonic tissue derived from GF mice exhibited diminished NADH/NAD+ ratios and ATP levels as compared to colonic tissue derived from CONV-R mice . Other tissues surveyed, however, showed no difference in these same energetic biomarkers between GF and CONV-R mice, thereby suggesting a selective role of microbiota in regulating energy homeostasis in the colon. The most likely reason for this tissue specificity is that colonocytes utilize bacterially-produced butyrate as their primary energy source , , whereas most other cell types rely on glucose. Butyrate is a short-chain fatty acid (SCFA) produced by bacterial fermentation of fiber in the lumen of the proximal colon, and we demonstrated that butyrate rescues a severe deficit in oxidative metabolism in GF colonocytes . However, we were surprised that glucose did not compensate for the lack of butyrate in GF colonocytes because most or all cells have the capacity to metabolize glucose. Here, in this study, we address this issue experimentally by analyzing glucose uptake and metabolism in GF and CONV-R colonocytes. We also demonstrate that the perturbed metabolic state of GF colonocyte results in a partial block in the cell-cycle as compared to CONV-R colonocytes, and that feeding GF mice a butyrate-fortified diet incompletely rescue this cell-cycle block in the GF colonocyte.
Effect of Microbiota on Energy Homeostasis in Different Segments of the GI Tract
We previously demonstrated that microbiota are required for normal ATP levels in the colon but not in several other tissues that were tested . Here, we extended this analysis to different segments of the GI tract because it is known to harbor the highest densities of microbes in the body. In addition to the stomach, small intestine (jejunum and ileum), proximal colon, and distal colon, we also analyzed liver and fat (white adipose tissue) because of their important roles in digestion and metabolism. The proximal colon, but none of the other tissues that were tested including the distal colon, had significantly diminished ATP levels in GF mice compared to CONV-R controls (Figure 1A). AMPKα (5′-adenosine monophosphate-activated protein kinase a) is a metabolic sensor activated by low ATP levels relative to AMP. Therefore, we evaluated AMPKα activation status based on increased Thr172 phosphorylation. As expected, we observed an increase in AMPKα activation in the proximal colon of GF mice relative to CONV-R but not in the distal colon or small intestine (Figure 1B). These results extend our previous findings  showing that the energetic deficit is not observed in all GI segments, and support the idea that the proximal colon is particularly dependent on microbiota.
A, ATP levels in the stomach (S), small intestine (SI), proximal colon (PC), distal colon (DC), liver (L), and fat (F) (white adipose tissue) of CONV-R and GF mice. Five CONV-R and five GF mice were analyzed, and the results are mean ± standard error. Significant differences are indicated (*p<0.05). B, Western blot analysis of AMPKα phosphorylated at Thr172 (top panel) and total AMPKα (bottom panel) in different segments of the colon and small intestine from GF and CONV-R mice. Results are representative of 3 independent experiments.
GF Colonocytes Exhibit Increased Glucose Uptake and Glycolysis
To understand the effects of microbiota on colonocyte metabolism, we analyzed our previous transcriptome profile data comparing freshly isolated colonocytes from CONV-R and GF mice . This analysis revealed that cell-surface transporters were among the most highly enriched gene products upregulated in GF colonocytes. For example, 26 members of solute carrier (SLC) families were upregulated, whereas only 7 were downregulated (Table S1). The SLC2 family encodes facilitative (ATP-independent) glucose transporters (GLUTs), and 3 out of 13 members were upregulated in GF (Table S1). Most GLUTs are not expressed ubiquitously so having a subset of them affected was expected. The SLC5A family encodes active (ATP-dependent) glucose transporters. Members of this family are also expressed in a tissue-restricted manner, and 2 out of 12 were upregulated in GF including one (SLC5A1) known to function in the intestine (Table S1). Members of other SLC families that were upregulated are known to take up other energy substrates such as fatty acids and amino acids (Table S1). These findings suggest that GF colonocytes attempt to compensate for the lack of butyrate by increasing their uptake of glucose and other alternative energy substrates. To investigate whether the increased expression of glucose transporters is functionally relevant and results in increased glucose uptake, we isolated colonocytes from CONV-R and GF mice in the presence of 6-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-d-glucose (6-NBDG), which is a fluorescent glucose analog, and analyzed its uptake ex vivo. Confocal microscopy was performed within an hour of colonocyte isolation, and 6-NBDG levels were 3.5-fold higher inside of GF colonocytes than CONV-R controls (Figure 2).
A, 2-deoxyglucose uptake observed as green fluorescence in CONV-R (left) and GF (right) colonocytes counterstained with DAPI (blue). B, Quantification of total 2-deoxyglucose fluorescence per cell in CONV-R and GF colonocytes. Results are based on 20 cells per colonocyte preparation from 3 independent mice and represent the mean ± SE with significant differences indicated (*p<0.01).
6-NBDG cannot be oxidized, which makes it ideal for measuring glucose uptake but not suitable for measuring glycolysis. To evaluate glycolysis, it was first necessary to analyze substrate availability so we measured glucose levels in the serum of CONV-R and GF mice. Similar to a previous finding , we observed a mild hypoglycemia in GF mice compared to CONV-R controls (Figure 3A). Next, we measured intracellular glucose, two key intermediates of glycolysis (glucose-6-phosphate and pyruvate), and lactate (the final end product of glycolysis) inside of colonocytes. GF colonocytes had a ∼25% decrease in intracellular glucose, glucose-6-phosphate, and pyruvate levels compared to CONV-R, whereas lactate levels were increased 3.5 fold compared to CONV-R (Figure 3B–E). These results suggest that glucose is taken up by GF colonocytes in greater quantities but it does not accumulate because the rate of glycolysis is also increased to an extent that yields a commensurate increase in lactate.
A–E, Levels of serum glucose (A), intracellular glucose (B), glucose-6-phosphate (Glu-6-P) (C), pyruvate (D), and lactate (E) in CONV-R and GF serum (A) or colonocytes (B–E). Results are mean ± standard error from 3 independent experiments with significant differences indicated (*p<0.05; **p<0.01).
Glucose is Not Metabolized Oxidatively by GF Colonocytes
When a single molecule of glucose is metabolized by glycolysis to lactate, it yields only 2–4 ATPs; in contrast, when glucose is converted to pyruvate followed by oxidative metabolism inside mitochondria, it yields 36 ATPs. Considering that GF colonocytes are in a suboptimal energetic state, it is surprising that they metabolize glucose to lactate rather than oxidatively to CO2. To demonstrate that oxidative metabolism is, in fact, diminished in GF colonocytes, we performed flux experiments by adding uniformly labeled 13C-labeled glucose to primary colonocytes as they were being isolated from CONV-R and GF mice and then measuring 13C-labeled CO2 using gas isotope ratio mass spectrometry. These experiments demonstrated that in GF colonocytes, 13C(6)-glucose is oxidized to 13CO2 at only 51% of the normal oxidation rate that occurs in CONV-R colonocytes (Figure 4A).
A, Levels of free 13CO2 released from CONV-R and GF colonocytes following their incubation with uniformly labeled (13C(6)) or singly labeled (13C(1)) glucose. 13CO2 levels were detected by isotope-ratio mass spectrometry, and the results are presented as mean ± standard error from 3 independent experiments with significant differences indicated (*p<0.01). B, Oxidative metabolism indicated by MitoTracker Red CM-H2XRos (red fluorescence; second column) and total mitochondria indicated by the non-oxidizable MitoTracker Green FM (green fluorescence; first column) in colonocytes from CONV-R (top two rows) and GF (bottom three rows). The sodium azide treated cells in the second row serve as a negative control. The effect of glucose and butyrate on GF colonocytes in the two bottom rows is compared to untreated GF colonocytes in the row immediately above. C, Quantification of oxidative metabolism in the different experimental groups. Determined as the ratio of red fluorescence relative to green fluorescence (internal control). Results are based on 20 cells per condition from 3 independent experiments and represent the mean ± SE with significant differences indicated (*p<0.01). D, Spectral counts from quantitative mass spectrometry of pyruvate dehydrogenase subunits in CONV-R and GF colonocytes. E, Western blot analysis of the E1α and E1b subunits of PDF from CONV-R and GF colons with β–actin serving as a loading control. Results are representative of 3 independent experiments. F, Western blot analysis of phospho-PDH (E1α) and total PDH (E1α) from CONV-R and GF colons. Results are representative of 3 independent experiments.
Diminished CO2 production should be coupled to diminished oxidative phosphorylation, which we analyzed by incubating primary colonocytes with two mitotracker probes simultaneously. One probe fluoresced red upon being oxidized and provided a measure of oxidative phosphorylation, while the other probe fluoresced green regardless of mitochondrial oxidative activity and therefore served as an internal control. As described previously , GF colonocytes exhibited a marked decrease in mitochondrial oxidative activity (red in row 3, column 2) but showed no difference in total mitochondria (green in row 3, column 1) (Figure 4B). The extent to which oxidative phosphorylation was diminished in GF colonocytes is striking because it was more similar to sodium azide treated negative controls (red in row 2, column 2) than CONV-R samples (red in top row, column 2). Next, we added glucose to GF colonocytes and observed only a modest increase in oxidative metabolic activity (red in row 4, column 2) (Figure 4B,C). In contrast, when we added butyrate to GF colonocytes, it stimulated such a large increase in oxidative metabolic activity that it was comparable to CONV-R controls (red in bottom row, column 2) (Figure 4B,C). These results indicate that although GF colonocytes are competent to undergo oxidative metabolism (based on the short-chain fatty acid butyrate), they metabolize glucose primarily by glycolysis rather than oxidatively via the TCA cycle and oxidative phosphorylation.
PDH Inhibition Prevents Glucose from being Oxidized by GF Colonocytes
Because butyrate stimulates oxidative activity in GF colonocytes, the mitochondrial enzymes involved in the TCA cycle and electron transport chain must be functional. Therefore, the inability of glucose to stimulate robust oxidative metabolism must be due to an alteration specific to glucose metabolism (i.e., not involving enzymes that also participate in butyrate metabolism). We previously performed a proteomic analysis to identify protein expression differences between CONV-R and GF colonoytes . Further analysis of these data revealed a significant decrease in the levels of the E1α, E1β, and E2 subunits of the pyruvate dehydrogenase (PDH) complex in GF compared to CONV-R colonocytes (Fig. 4D). PDH is a particularly good candidate because it facilitates oxidative glucose metabolism by converting cytosolic pyruvate to mitochondrial acetyl-CoA immediately upstream of the TCA cycle , but is not involved in fatty acid metabolism. Accordingly, downregulation of PDH would be expected to result in decreased oxidative metabolism of glucose and a concomitant rise in glycolysis (i.e., lactate production). To validate the mass spectrometry results, we performed western blot analyses for PDH-E1a and PDH-E1b subunits and found that their level of expression was markedly diminished in GF colonocytes compared to CONV-R colonocytes (Figure 4E). We hypothesized that PDH activity would also be diminished in GF because of increased mRNA levels of pyruvate dehydrogenase kinase 2 (Pdk2) (based on analysis of our previous transcriptome data ), which phosphorylates and inactivates the E1α regulatory subunit . To test this hypothesis, we analyzed levels of PDH-E1a phosphorylated at Ser293. Despite total PDH-E1a being diminished, phospho-PDH-E1a was increased (Figure 4E). Low levels of PDH-E1a combined with the fact that a relatively large percentage of the molecules are inactivated by phosphorylation suggested that PDH activity should be diminished in GF colonocytes. To test this hypothesis, we performed flux experiments using singly-labeled glucose (13C(1)-glucose) rather than uniformly labeled glucose (13C(6)-glucose) because the first CO2 that is released (in this case as 13CO2) is due to PDH. Analysis of CONV-R and GF colonocytes incubated with 13C(1)-glucose revealed that PDH activity was diminished in GF by 94% (Figure 4A). Taken together, these experiments provide an explanation for why GF colonocytes undergo increased glycolysis and decreased oxidative metabolism.
GF Colonocytes Have a Cell-Cycle Defect
The perturbed energy metabolism of GF colonocytes might be expected to have deleterious consequences, and we previously determined that these cells undergo increased autophagy . Based on our analysis of transcriptome profiles, we also identified decreased expression of many histone genes. The four canonical histones (H2A, H2B, H3, and H4) are each represented by 12–17 genes arranged in 3 clusters . The largest of these clusters (Hist1) covers a large genomic interval (∼2 Mbp) and contains the majority of the core histone genes plus all 6 of the linker histone (H1) genes. Out of 64 histone genes, 27 were downregulated in GF while none were upregulated (Table S2). The extent of downregulation averaged 1.7 fold with a range of 1.4 to 2.1 (Table S2). Because each of these histone genes is transcribed only during DNA replication , this finding suggested that a lower percentage of GF colonocytes are in S phase than CONV-R colonocytes.
To confirm that the histone genes were serving as an accurate marker of S phase and that GF colonocytes have a cell-cycle defect, we performed flow cytometery to quantify the percentage of cells in various stages of the cell cycle. Using BrdU to detect cells in S phase and propidium iodide (PI) as a measure of DNA content, these experiments demonstrated that GF mice have an ∼80% reduction in colonocytes undergoing DNA replication in S-phase (Figure 5A). 1.3% of GF colonocytes were in S phase compared to 6.5% for CONV-R (Figure 5A). There was no significant difference in the distribution of cells in early versus late S phase suggesting DNA replication progression is not perturbed. However, 61.5% of GF colonocytes were in G1 compared to 53.8% for CONV-R controls. The increased percentage of GF colonocytes in G1 coupled with the decreased percentage in S phase suggests there was a partial block in the transition from G1 to S phase. This result was consistent in three independent experiments and suggests that the suboptimal energetic state of GF colonocytes decreased cell-cycle progression at the G1 to S phase transition. The GF samples also showed an increased percentage of cells in G2 suggesting that there was also a partial block at the G2 to M phase transition, which represents the other major cell-cycle checkpoint.
A, Flow cytometry profiles of colonocytes from CONV-R mice (left), GF mice (center), and GF mice provided a tributyrin-fortified diet (right). PI levels are shown on the x-axis, and BrdU incorporation is shown on the y-axis. The percentage of cells in various stages of the cell cycle are indicated: P1, G1; P2, early S; P3, middle S; P4, late S; P5, G2. Results are representative of 3 independent experiments. B, Measurements of luminal butyrate (left) and tributyrin (right) levels from the colon of CONV-R mice and GF mice provided either a provided a control diet (GF) or a tributyrin-fortified diet (GF + Tributyrin). Results are mean ± standard error from 3 independent experiments with significant differences indicated (*p<0.01). N.D., not detectable.
Although the above findings demonstrate the importance of microbiota in cell-cycle progression, they do not address whether butyrate is a causal factor. Therefore, we provided GF mice with an identical diet that was calorically matched except it was fortified with tributyrin. Tributyrin is more stable than butyrate (i.e., less is absorbed in the small intestine before it reaches the colon) and is converted into 3 butyrate molecules in the colon. Our LC-MS/MS analysis of luminal contents of these mice confirmed that tributyrin was efficiently converted to butyrate in the colon based on the concentration of tributyrin being only ∼25% of butyrate (Figure 5B). Whereas butyrate was not detectable in the colon of GF mice provided the control diet, butyrate levels were greater than 1 mM in GF mice provided the tributyrin-containing diet. This level was 36% of that measured in CONV-R mice (Figure 5B). Cell-cycle analysis of GF colonocytes using BrdU and PI showed that the tributyrin diet partially rescued the G1-to-S phase block (Figure 5A). The percentage of cells in S phase (2.4%) and in G1 (57.4%) was intermediate between the CONV-R and GF samples. This rescue is consistent with our finding that butyrate stimulates oxidative metabolism in GF colonocytes (Figure 4B,C) and identifies butyrate as bacterial metabolite that can promote cell-cycle progression of mammalian host cells.
In this study we demonstrate that microbiota promote glucose metabolism at two levels. At a systemic level, microbiota increase blood glucose levels since GF mice are mildly hypoglycemic, which is consistent with a previous report . This is consistent with the idea that the gut microbiome is highly enriched for genes encoding glycoside hydrolases and polysaccharide lyases that convert glycans into simple sugars that are absorbed in the small intestine. At a local level, microbiota also influence how glucose is utilized by colonocytes, and this is presented as a model in Figure 6. Based on comparisons between CONV-R and GF colonocytes, microbes promote oxidative metabolism by increasing PDH levels and enzymatic activity to direct glucose-derived carbon into the TCA cycle. This is apparent from the results of our experiments showing that GF colonocytes take up increased levels of glucose but shift away from oxidative metabolism/CO2 production and towards glycolysis and lactate production. Although this metabolic shift apparently does not occur in GF liver , it might occur in other GF tissues since GF mice consume less oxygen than CONV-R controls . The increased glucose uptake in GF colonocytes presumably represents an attempt to compensate for the loss of their preferred energy substrate, which is bacterial-produced butyrate. However, the downregulation of PDH and shift to glycolysis does not yield enough ATPs to compensate. Unlike tumor cells undergoing the Warburg effect, it is not clear how this shift to glycolysis would be advantageous to GF colonocytes. Considering that ATP levels of GF colonocytes are approximately half of CONV-R controls, this shift from oxidative metabolism to glycolysis might be viewed as a pathological condition that prevents increased glucose uptake from compensating. The mammalian genome co-evolved with the gut microbiome so it is not surprising that metabolic defects arise in the GF condition.
Microbes increase blood glucose levels and increase PDH levels and activity to facilitate oxidative metabolism of glucose in the mitochondria. In contrast, GF mice are hypoglycemic, and their colonocytes respond by increased expression of GLUTs. Although this leads to increased glucose uptake, Glu-6-P and pyruvate levels are diminished because of their conversion to lactate, which is increased in GF colonocytes. This increase in glycolysis can be attributed to decreased PDH expression/activity and decreased oxidative metabolism in the mitochondria. Not only are PDH levels decreased, but also enzymatic activity is inhibited via phosphorylation of the E1a regulatory subunit due to increased expression of PDK2 in GF colonocytes.
The decreased ATP levels in GF colonocytes leads to AMPK activation as shown here and autophagy as shown previously . One might expect decreased ATP levels to result in additional deleterious consequences, and here we demonstrate that cell-cycle progression is diminished at the transition from G1 to S phase. One possibility is that a nutrient sensing pathway, possibly involving AMPK, regulates the restriction point of the cell cycle. However, other possibilities cannot be excluded. For example, we did not observe energy homeostasis perturbations in the GF small intestine, yet this tissue also shows diminished cell proliferation based on previous studies that measured [3H]-thymidine incorporation in GF samples compared to CONV controls , . However, in our experiments, we know that butyrate is a causal factor because providing GF mice with tributyrin partially rescued the G1-to-S phase block. Because butyrate is the preferred energy source of colonocytes, our work supports the idea that the cell-cycle defect in GF colonocytes arises because of suboptimal energy metabolism.
Materials and Methods
Ethics Statement and mice
All mouse experiments were approved by the Institutional Animal Care and Use Comittees (IACUC) review board at the University of North Carolina as approved protocol ID # 10-186 and were performed in accordance with federal guidelines. Eight- to fourteen-week-old CONV-R or GF male C57BL/6 mice were used in all experiments, with the exception of ATP experiments, which used BALB/c mice. Conventionally-raised mice were reared in a specific pathogen-free (SPF) facility, while germfree mice were maintained in a gnotobiotic facility. Light/dark cycles and animal husbandry practices were identical between the facilities except that aseptic technique was performed in the gnotobiotic facility. For the flow cytometry experiments, the tributyrin-fortified (5AVC) and control (5SRZ) diets were from Test Diet (Richmond, IN).
Isolation of Colonocytes
Colonic epithelial cells were isolated according to  in order to exclude cell types other than colonocytes such as immune cells, smooth muscle, and enteric neurons. Briefly, animals were euthanized by CO2 asphyxiation followed by cervical dislocation. Proximal colons were dissected, flushed with sterile Phosphate-buffered Saline (PBS), and splayed open longitudinally along Whatmann paper. The colon was then washed 3 more times in PBS, pealed from paper, and placed in PBS solution containing 5 mM EDTA. Submerged colon was then incubated on a rotator for 30 minutes at 37°C. After 30 minutes, colonic tissue was removed leaving isolated colonocytes, which were washed twice with PBS, and used for experiments.
Cells or tissues were flash-frozen and homogenized or agitated in 8.3 M urea lysis buffer with NaF and Na orthovanadate and incubated on wet ice for 30 minutes. Samples were then centrifuged at 14,000 rpm for 20 minutes at 4°C. Protein supernatant was transferred to a new 1.5 mL eppendorf tube and protein concentration was determined by Bradford assay. Protein homogenates were separated on 10, 12, and 4–20% gradient SDS-polyacrylamide gels and transferred onto PVDF membrane. Membranes were then incubated on rocker in 3% BSA or 5% non-fat dry milk with NaF for 1 hr at RT. Blocked membranes were incubated in 1°Ab overnight on rotator at 4°C. Antibodies were used at 1∶250 to 1∶2000 and included AMPKα (Cell Signaling, Danvers, MA), phospho-AMPKα (Cell Signaling), pyruvate dehydrogenase cocktail (Mitosciences, Eugene, OR; MSP02), phospho-PDH-E1a (Abcam; ab92696), and β-actin (Abcam; ab8226). Blots were washed 3X for 10 min/wash in 1X TBST or 1X PBST (for non-phospho Westerns) at RT and incubated with horseradish peroxidase-conjugated secondary antibodies (1∶2000 to 1∶4000) for 1 hr and 30 min on rocker at room temperature. Membranes were then washed 3 additional times in 1XTBST or 1XPBST (for non-phospho Westerns), treated with ECL reagent, and developed for analysis.
All metabolic assays were performed with Biovision (Mountain View, CA) metabolism kits. Specifically, ATP (K354-100), glucose (K606-100), glucose-6-phosphate (K657-100), pyruvate (K609-100), and lactate (K607-100) were used in accordance to manufacturer specifications. For all assays, flash-frozen tissue was deproteinized with Perchloric acid kit (K808-200), which was also from Biovision. Results represent 4–6 independent biological replicates.
The reagents 6-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-d-glucose (6-NBDG), MitoTracker Red CM-H2XRos, and MitoTracker Green FM were purchased from Invitrogen (Carlsbad, CA). For 6-NDBG uptake assessment, 1 µM 6-NDBG was added to PBS/EDTA solution while isolating colonocytes (see above). Colonocytes were stained with DAPI and mounted on slides with coverslip. Cells were viewed with Olympus IX81 microcope equipped with FITC, Texas Red, Rhodamine, and DAPI filters. All fluorescent micrographs were acquired with the same exposure and focal plane. Image J (Bethesda, MD) was used to quantify integrated density (total fluorescence) per cell.
In a manner similar to the 6-NDBG, mitotracker dyes were added at 500 nM (MitoTracker Red CM-H2XRos), and 500 nM (MitoTracker Green FM) while isolating colonocytes. Image J was used to analyze mean fluorescence for both mitotracker dyes. The red-to-green fluorescence is an indication of oxidative metabolism in the colonocytes. All micrographs were taken with identical exposures. Z-stacks were acquired for each image and for each cell the individual z-stacks did not differ in red-to-green mean fluorescence between focal planes. For both 6-NDBG and mitotracker experiments, we used 3 independent biological replicates per experimental group.
Liquid Chromatography - Mass Spectrometry
GF mice were given a tributyrin-fortified diet over a two-week period, Endogenous butyrate and tributyrin were measured from luminal contents of CONV-R and GF mice. An internal 13C1-butyrate standard was added, and luminal contents were resuspended in 0.1% ammonium hydroxide. Proteins were removed by centrifugation through 3-kDa spin-filters. Flow through was then analyzed for butyrate or tributyrin content by HPLC separation with subsequent detection by an Agilent 6520 AccurateMass Q-TOF mass spectrometer operating in negative mode (Santa Clara, CA). Peak areas were calculated using MassHunter Workstation software. Chromatographic peaks were integrated for samples and areas were compared to peak area for standards (10 µM) for each compound.
Isotope Ratio Mass Spectrometry
The amount of 13CO2 in Exetainer breath storage tubes generated from colonocytes was measured with a Europa Scientific 20/20 gas isotope ratio mass spectrometer (Europa Scientific, Cincinnati, OH). Dissolved CO2 in solution was liberated to the tube headspace by addition of 100 mL saturated citric acid. The ratio of 13CO2 to 12CO2 (mass 45 to 44) was measured directly from the sample tube headspace. All samples were compared to an internal reference gas (5% CO2, balance 75% N2, 20% O2) that had been calibrated against the international standard PeeDeeBelmnite (PDB). Changes in 13CO2 enrichment before and after glucose administration were calculated. CO2 standards at three different 13C enrichments were run before and after the run to check instrument performance. The analytical precision of the instrument is 0.0001 atom % 13C.
Mice received i.p. injections of BrdU (50 mg/kg body weight) and colonocytes were prepared (as described above) 2 hours later. Following wash steps, 2×106 colonocytes in 1 mL of PBS were fixed by the addition of 3 mL of ice-cold ethanol. This was done dropwise while vortexing. Following fixation, 1 mL of 50 mg/mL propidium iodide and 50 mL of 10 mg/mL of RNAse A was added and incubated at 4°C for 3 hours. For flow cytometry, mouse anti-BrdU followed by goat-anti-mouse IgG FITC incubation/wash steps were followed by flow cytometry following standard procedures.
SLC Gene Expression Changes in GF Colonocytes. Data are derived from a transcriptome analysis from CONV-R and GF colonocytes.
We thank V. Madden, S. Ray, and B. Bagnell at the UNC Micrsocopy Services Laboratory for advice with confocal microscopy. We would also like to thank L. Collin at the UNC Biomarker Mass Spectrometry Facility (supported by NIH grant P30-ES10126) for his technical assistance in performing the LC-MS/MS experiments. Finally, we would like to thank the staff of the National Gnotobiotic Resource Center at UNC for maintaining germfree mice.
Conceived and designed the experiments: DRD SJB. Performed the experiments: DRD AW BPB. Analyzed the data: DRD AW. Wrote the paper: DRD SJB.
- 1. Huttenhower C GD, Knight R, Abubucker S, Badger JH, et al. (2012) Structure, function and diversity of the healthy human microbiome. Nature 486: 207–214.
- 2. Methé BA NK, Pop M, Creasy HH, Giglio MG, et al. (2012) A framework for human microbiome research. Nature 486: 215–221.
- 3. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, et al. (2006) Metagenomic analysis of the human distal gut microbiome. Science 312: 1355–1359.
- 4. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, et al.. (2009) High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137: : 1716–1724 e1711–1712.
- 5. Kurokawa K, Itoh T, Kuwahara T, Oshima K, Toh H, et al. (2007) Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 14: 169–181.
- 6. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59–65.
- 7. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, et al. (2009) A core gut microbiome in obese and lean twins. Nature 457: 480–484.
- 8. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, et al. (2007) The human microbiome project. Nature 449: 804–810.
- 9. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, et al. (2012) Human gut microbiome viewed across age and geography. Nature 486: 222–227.
- 10. Savage DC (1977) Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31: 107–133.
- 11. Turnbaugh PJ, Gordon JI (2009) The core gut microbiome, energy balance and obesity. J Physiol 587: 4153–4158.
- 12. Hooper LV, Gordon JI (2001) Commensal host-bacterial relationships in the gut. Science 292: 1115–1118.
- 13. Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022–1023.
- 14. Dethlefsen L, McFall-Ngai M, Relman DA (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449: 811–818.
- 15. Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, et al. (2008) Evolution of mammals and their gut microbes. Science 320: 1647–1651.
- 16. Martens EC, Chiang HC, Gordon JI (2008) Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe 4: 447–457.
- 17. Hooper LV, Falk PG, Gordon JI (2000) Analyzing the molecular foundations of commensalism in the mouse intestine. Curr Opin Microbiol 3: 79–85.
- 18. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host-bacterial mutualism in the human intestine. Science 307: 1915–1920.
- 19. Hooper LV, Midtvedt T, Gordon JI (2002) How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22: 283–307.
- 20. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027–1031.
- 21. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101: 15718–15723.
- 22. Gordon HA, Pesti L (1971) The gnotobiotic animal as a tool in the study of host microbial relationships. Bacteriol Rev 35: 390–429.
- 23. Donohoe DR, Garge N, Zhang X, Sun W, O'Connell TM, et al. (2011) The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 13: 517–526.
- 24. Roediger WE (1980) Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21: 793–798.
- 25. Roediger WE (1982) Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83: 424–429.
- 26. Sugden MC, Holness MJ (2006) Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases. Arch Physiol Biochem 112: 139–149.
- 27. Marzluff WF, Gongidi P, Woods KR, Jin J, Maltais LJ (2002) The human and mouse replication-dependent histone genes. Genomics 80: 487–498.
- 28. Sewell DL, Wostmann BS, Gairola C, Aleem MI (1975) Oxidative energy metabolism in germ-free and conventional rat liver mitochondria. Am J Physiol 228: 526–529.
- 29. Khoury KA, Floch MH, Hersh T (1969) Small intestinal mucosal cell proliferation and bacterial flora in the conventionalization of the germfree mouse. J Exp Med 130: 659–670.
- 30. Savage DC, Siegel JE, Snellen JE, Whitt DD (1981) Transit time of epithelial cells in the small intestines of germfree mice and ex-germfree mice associated with indigenous microorganisms. Appl Environ Microbiol 42: 996–1001.
- 31. Roediger WE, Truelove SC (1979) Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut 20: 484–488.